Cormorant Asset Management, LP - Former 10% Owner at Jade Biosciences, Inc.

Issuer-level insider activity

Role
Former 10% Owner
Issuer ticker
JBIO on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Cormorant Asset Management, LP since 18 Aug 2025

Reported holdings for Cormorant Asset Management, LP in Jade Biosciences, Inc.

Form 4 holding Former 10% Owner

Aerovate Therapeutics, Inc.

Security class
Common Stock
Shares / value
2,030,691
Estimated value
$39,598,475
Report date
02 Jul 2021
Price
$19.50
Ownership
Indirect
Form 4 holding Former 10% Owner

Aerovate Therapeutics, Inc.

Security class
Series A Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
02 Jul 2021
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount

Transaction history for Cormorant Asset Management, LP in Jade Biosciences, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .